Gulf War and Health: Volume 1. Depleted Uranium, Sarin, Pyridostigmine Bromide, and Vaccines
THE NATIONAL ACADEMIES
Institute of Medicine
Division of Health Promotion and Disease Prevention
Committee on Health Effects Associated with Exposures During the Gulf War
Wednesday, September 6, 2000 - 1:00 p.m.
412 Russell Senate Office Building
Gulf War and Health: Volume 1.
Depleted Uranium, Sarin, Pyridostigmine Bromide, and Vaccines
Members of the Committee on Health Effects Associated with Exposures During the Gulf War, led by Harold C. Sox Jr., professor and chair, department of medicine, Dartmouth-Hitchcock Medical Center, Lebanon, N.H., and chair, Committee on Health Effects Associated with Exposures During the Gulf War, Division of Health Promotion and Disease Prevention, Institute of Medicine, The National Academies
Veterans who have experienced chronic health problems following their service in the Gulf War question whether exposure to chemical and biological agents may be responsible. Requested by Congress in PL105-368, a new report from an Institute of Medicine committee assesses the scientific evidence on the potential health effects of depleted uranium, sarin, pyridostigmine bromide, and vaccines to protect against anthrax and botulism. Since little research has been done on Gulf War veterans, most of this evidence was drawn from occupational settings, terrorist attacks, and clinical trials.
This was the first in a series of briefings for members of Congress and congressional staff only. The report was released at a public briefing on September 7, 2000 at the National Academies in Washington, D.C. The full text is available online through the Web site of the National Academies Press.